Infantile Spasms without Hypsarrhythmia and Paroxysmal Eye–Head Movements in an Infant with a Pyridoxine-Dependent Epilepsy due to PLPBP/PLPHP Deficiency

Abstract

To describe a new phenotype and the diagnostic workup of a vitamin-B₆-dependent epilepsy due to pyridoxal 5′-phosphate-binding protein (PLPBP) deficiency in an infant with early-onset epilepsy at the age of 5 years 6 months. Following immediate and impressive clinical response to treatment with pyridoxine, metabolic screening for vitamin-B₆-dependent epilepsies and targeted next-generation sequencing (NGS)-based gene panel analysis were performed. Potentially pathogenic variants were confirmed by Sanger sequencing in the patient, and variants were analyzed in both parents to confirm biallelic inheritance. The clinical phenotype and course of disease were compared to the 44 cases reported in the literature, harboring variants in pyridoxal phosphate homeostasis protein (PLPHP) and with cases of vitamin-B₆-dependent epilepsy due to other known causative genes. Levels of alpha-aminoadipic semialdehyde in urine and amino acids were normal. Two inherited pathogenic variations in PLPHP were found in compound heterozygosity, including one novel deletion. We here describe a previously unreported individual harboring biallelic pathogenic PLPHP variants presenting with paroxysmal eye–head movements followed by epileptic spasms and an almost normal interictal electroencephalogram, thus expanding the clinical spectrum of PLPBP deficiency. This warrants consideration of vitamin-B₆-dependent epilepsies in patients with early-onset epilepsy, including epileptic spasms, and eye movement disorders also beyond the neonatal period even when metabolic screening for vitamin-B₆-dependent epilepsies is negative. PLPHP should be included systematically in NGS epilepsy gene panels.

Keywords

pyridoxine - vitamin B₆ - paroxysmal movement disorder - epilepsy - West's syndrome - PROSC

Publication History

Received: 26 September 2022

Accepted: 21 December 2022

Accepted Manuscript online:
28 December 2022

Article published online:
24 February 2023

• References

• 1 Ahmed S, DeBerardinis RJ, Ni M, Afroze B. Vitamin B6-dependent epilepsy due to pyridoxal phosphate-binding protein (PLPBP) defect - first case report from Pakistan and review of literature. Ann Med Surg (Lond) 2020; 60: 721-727
• 2 Johannsen J, Bierhals T, Deindl P. et al. Excessive seizure clusters in an otherwise well-controlled epilepsy as a possible hallmark of untreated vitamin B6-responsive epilepsy due to a homozygous PLPBP missense variant. J Pediatr Genet 2019; 8 (04) 222-225
• 3 Pal M, Lace B, Labrie Y. et al. A founder mutation in the PLPBP gene in families from Saguenay-Lac-St-Jean region affected by a pyridoxine-dependent epilepsy. JIMD Rep 2021; 59 (01) 32-41
• 4 Heath O, Pitt J, Mandelstam S, Kuschel C, Vasudevan A, Donoghue S. Early-onset vitamin B₆-dependent epilepsy due to pathogenic PLPBP variants in a premature infant: a case report and review of the literature. JIMD Rep 2020; 58 (01) 3-11
• 5 Wilson MP, Plecko B, Mills PB, Clayton PT. Disorders affecting vitamin B₆ metabolism. J Inherit Metab Dis 2019; 42 (04) 629-646
• 6 Caraballo RH, Ruggieri V, Gonzalez G. et al. Infantile spams without hypsarrhythmia: a study of 16 cases. Seizure 2011; 20 (03) 197-202
• 7 Marchi LR, Seraphim EA, Corso JT. et al. Epileptic spasms without hypsarrhythmia in infancy and childhood: tonic spasms as a seizure type. Epileptic Disord 2015; 17 (02) 188-193
• 8 Jiao X, Gong P, Niu Y, Zhang Y, Yang Z. A rare presentation characterized by epileptic spasms in ALDH7A1, pyridox(am)ine-5′-phosphate oxidase, and PLPBP deficiency. Front Genet 2022; 13: 804461
• 9 Gibaud M, Barth M, Lefranc J. et al. West syndrome is an exceptional presentation of pyridoxine- and pyridoxal phosphate-dependent epilepsy: data from a French cohort and review of the literature. Front Pediatr 2021; 9: 621200
• 10 Prunetti L, El Yacoubi B, Schiavon CR. et al. Evidence that COG0325 proteins are involved in PLP homeostasis. Microbiology (Reading) 2016; 162 (04) 694-706
• 11 Johnstone DL, Al-Shekaili HH, Tarailo-Graovac M. et al; Care4Rare Canada Consortium. PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights. Brain 2019; 142 (03) 542-559
• 12 Fung CW, Kwong AKY, Wong VCN. Gene panel analysis for nonsyndromic cryptogenic neonatal/infantile epileptic encephalopathy. Epilepsia Open 2017; 2 (02) 236-243
• 13 Mills PB, Camuzeaux SSM, Footitt EJ. et al. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. Brain 2014; 137 (Pt 5): 1350-1360
• 14 Koul R, Alfutaisi A, Abdelrahim R, Altihilli K. Pyridoxine responsive seizures: beyond aldehyde dehydrogenase 7a1. J Neurosci Rural Pract 2019; 10 (04) 613-616
• 15 Pearson TS, Pons R, Engelstad K, Kane SA, Goldberg ME, De Vivo DC. Paroxysmal eye-head movements in Glut1 deficiency syndrome. Neurology 2017; 88 (17) 1666-1673